NCT05954624View on ClinicalTrials.gov

Drug-durg Interaction of ZSP1273 With Digoxin, Rosuvastatin,Itraconazole and Probenecid

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

July 10, 2023

Primary Completion Date

November 20, 2023

Study Completion Date

November 30, 2023

Conditions
Drug Drug Interaction
Interventions
DRUG

Digoxin

oral

DRUG

Rosuvastatin

oral

DRUG

ZSP1273

oral

DRUG

Itraconazole

oral

DRUG

Probenecid

oral

Trial Locations (1)

Unknown

The First Affiliated Hospital of Guangzhou University of Chinese medicine, Guangzhou

All Listed Sponsors
lead

Guangdong Raynovent Biotech Co., Ltd

INDUSTRY